Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Apr 2021 - Mar 2022
Lobbyists (Full time equivalent)
1.25 Fte (3)
Lobbyists with EP accreditation
1
High-level Commission meetings
5
Lobbying Costs over the years
-
Info
The European Association of Hospital Pharmacists (EAHP)
EU Transparency Register
82950919755-02 First registered on 18 Oct 2012
Goals / Remit
EAHP is an association of 35 national hospital pharmacy associations. Its mission is to represent and develop the hospital pharmacy profession within Europe to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals
In the interest of patients and public health, EAHP seeks to
- to promote and further develop hospital pharmacy and to obtain and maintain general joint pharmaceutical principles and a joint pharmaceutical policy;
- to foster research and education activities;
- to promote co-operation with other organisations in the domain of public health;
- to promote the position and function of hospital pharmacists;
- to support and uphold the interests of hospital pharmacists
Detailed information on the goals of EAHP can be found under https://www.eahp.eu/about-us/who-we-areMain EU files targeted
The main EU initiatives, policies and legislative files currently followed by EAHP include developments in:
- professional qualification recognition (e.g. the emergence of the common training framework tool, the European Professional Card, and developments associated with the Professional Qualifications Directive)
- access to medicines, including medicines shortages
- clinical trial regulation
- medical device regulation
- EU initiatives in the area of health systems
- tackling antimicrobial resistance, including the better use of antibiotics and an improved research environment for new antibiotics
- digital health
- patient safety
- the implementation of the Falsified Medicines Directive
- the European Medicines Agency, the Heads of Medicines Agencies, and European Directorate for the Quality of MedicinesAddress
Head Office
Boulevard Brand Whitlock 87
Brussels 1200 - Box 11
BELGIUMEU Office
Boulevard Brand Whitlock 87
Brussels 1200 - Box 11
BELGIUMWebsite
-
People
Total lobbyists declared
3
Employment time Lobbyists 50% 2 25% 1 Lobbyists (Full time equivalent)
1.25
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 30 Mar 2023
Name Start date End Date Ms Stephanie Kohl 21 Jun 2022 20 Jun 2023 Ms Stephanie Kohl 11 Mar 2020 11 Mar 2021 Mr Petr HORÁK 28 Feb 2020 27 Feb 2021 Ms Hildur Kristjana ÖNNUDÓTTIR 19 Jul 2019 01 Apr 2020 Ms Stephanie Kohl 06 Mar 2019 06 Mar 2020 Mr Petr HORÁK 26 Feb 2019 28 Feb 2020 Ms Valentina DIMULESCU 06 Nov 2018 20 Apr 2019 Mr Boris LAMBERT 20 Sep 2018 03 Oct 2018 Ms Stephanie Kohl 03 Mar 2018 02 Mar 2019 Mr Jordi MALLARACH PARÉS 14 Dec 2017 06 Sep 2018 Ms Stephanie Kohl 20 Mar 2017 01 Mar 2018 Mr Richard Perceval Price 10 Oct 2016 28 Apr 2017 Mr Richard Perceval-Price 03 Sep 2014 28 Aug 2015 Mr David Preece 03 Sep 2014 28 Aug 2015 Mr Roberto Frontini 08 Feb 2014 07 Aug 2014 Mr David Preece 17 May 2013 16 May 2014 Mr Richard Perceval-Price 11 Apr 2013 10 Apr 2014 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade unions and professional associations
-
Networking
Affiliation
EAHP is a member of the European Public Health Alliance (EPHA) and its access to medicines and AMR working groups. www.epha.org
EAHP is a member of the Federation of European & International Associations established in Belgium. www.faib.org
EAHP is a member of the International Pharmaceutical Federation (FIP). www.fip.org
EAHP is a member of the European Medicines Agency's Healthcare Professional's Working Party. http://www.ema.europa.eu/
EAHP is an affiliate stakeholder in the European Medicines Verification Organisation (EMVO) https://emvo-medicines.euMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Apr 2021 - Mar 2022
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
Medical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?groupID=3565 #Observer #C#Professionals
Groups (European Parliament)
N/A
Other activities
For more information about EAHP policy and advocacy activity visit www.eahp.eu > practice and policy
For more information about EAHP events visit www.eahp.eu > Events
For more information about EAHP publications visit www.eahp.eu > PublicationsMeetings
Meetings
5 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.
-
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Commission - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
Other Lobbyists - Phamaceutical Group of the European Union
- European Federation of Pharmaceutical Industries and Associations
- Novo Nordisk A/S
- Bureau Européen des Unions de Consommateurs
- Pfizer Inc.
- Fresenius Kabi Deutschland GmbH
- European Chemical Industry Council
- European Patients' Forum (EPF)
- MEDICINES FOR EUROPE
- Medichem, S.A.
- European Healthcare Distribution Association
- Leuphana Universität Lüneburg
- Teva Pharmaceuticals Europe BV
- SANOFI
-
Date 22 Sep 2020 Location Brussels Subject Exchange of views on the upcoming Pharmaceutical Strategy, shortages of medicines and the role of health workforce in the health systems Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Commission - Stella Kyriakides (Commissioner)
-
Date 22 Jul 2019 Location Brussels Subject Access to medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Commission - Arunas Vinciunas (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
- Alina Timofte (Cabinet member)
Other Lobbyists -
Date 01 Jul 2019 Location Brussels Subject • The current medicines shortages situation in Europe; • Our request for an investigation into the causes of shortages; and, • The general need for better information sharing about shortages. Commission - Anne Bucher (Director-General)
-
Date 03 May 2018 Location Brussels Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Commission - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
Other Lobbyists - European Society of Cardiology
- European Forum for Primary Care
- European Union of General Practitioners / Family Physicians (Union Européenne des Médecins Omnipraticiens / Médecins de Famille)
- European Society for Medical Oncology (ESMO)
- Standing Committee of European Doctors
- European Hospital and Healthcare Federation
- European Public Health Association
- Phamaceutical Group of the European Union
- European Organisation for Research and Treatment of Cancer